AMPS iShares Utilities Bond ETF AMPS buy or sell Buffett read basic profile
Ameriprise Financial, Inc. (NYSE:AMP) price target lowered to $145.00 by Credit Suisse...
Ameriprise Financial, Inc. (NYSE:AMP) price target lowered to $145.00 by Credit Suisse Group
Analyst Ratings For Ameriprise Financial, Inc. (NYSE:AMP)
Today, Credit Suisse Group lowered its price target on Ameriprise Financial, Inc. (NYSE:AMP) to $145.00 per share.
There are 5 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Ameriprise Financial, Inc. (NYSE:AMP) is Hold with a consensus target price of $166.00 per share, a potential 19.79% upside.
3/2/2018-Ameriprise Financial, Inc. (NYSE:AMP) has coverage initiated with a Buy rating and $217.00 price target
Recent Insider Trading Activity For Ameriprise Financial, Inc. (NYSE:AMP)
Ameriprise Financial, Amp Exchange Traded Funds
On 5/10/2018 James M Cracchiolo, CEO, bought 7,400 with an average share price of $136.04 per share and the total transaction amounting to $1,006,696.00.
On 5/2/2018 Walter Stanley Berman, VP, bought 3,728 with an average share price of $134.12 per share and the total transaction amounting to $499,999.36.
On 2/23/2018 Randy Kupper, EVP, sold 4,381 with an average share price of $159.61 per share and the total transaction amounting to $699,251.41.
500 with an average share price of $174.04 per share and the total transaction amounting to $957 Amp Exchange Traded Funds , EVP, sold 5,500 with an average share price of $174.04 per share and the total transaction amounting to $957,220.00.
On 1/26/2018 William F Truscott, CEO, sold 31,379 with an average share price of $173.64 per share and the total transaction amounting to $5,448,649.56.
On 12/22/2017 David Kent Stewart, Insider, sold 4,817 with an average share price of $171.51 per share and the total transaction amounting to $826,163.67.
On 12/8/2017 Joseph Edward Sweeney, Insider, sold 7,329 with an average share price of $169.47 per share and the total transaction amounting to $1,242,045.63.
Ameriprise Financial, Inc., through its subsidiaries, provides various financial products and services to individual and institutional clients in the United States and internationally. It operates through Advice & Wealth Management, Asset Management, Annuities, and Protection segments. The Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage services primarily to retail clients through its advisors. The Asset Management segment offers investment management and advice, and investment products to retail, high net worth, and institutional clients through unaffiliated third party financial institutions and institutional sales force. This segment's products include U.S. mutual funds and their non-U.S. equivalents, exchange-traded funds, variable product funds underlying insurance, and annuity separate accounts; and institutional asset management products, such as traditional asset classes, separately managed accounts, individually managed accounts, collateralized loan obligations, hedge funds, collective funds, and property funds. The Annuities segment provides variable and fixed annuity products to individual clients through affiliated and unaffiliated advisors, and financial institutions. The Protection segment offers various products to address the protection and risk management needs of retail clients, including life, disability income, and property casualty insurance through advisors and affinity relationships. The company was formerly known as American Express Financial Corporation and changed its name to Ameriprise Financial, Inc. in September 2005. Ameriprise Financial, Inc. was founded in 1894 and is headquartered in Minneapolis, Minnesota.
Recent Trading Activity for Ameriprise Financial, Inc. (NYSE:AMP)
Shares of Ameriprise Financial, Inc. closed the previous trading session at 138,64 −0,070 0,050 % with 138.44 shares trading hands.
Antares Pharma Inc (NASDAQ:ATRS) price target set to $5.00 by HC Wainwright
Arsanis Inc (NASDAQ:ASNS) had its Neutral ➝ Hold rating reiterated by Citigroup
Accuray Incorporated (NASDAQ:ARAY) price target lowered to $3.50 by Citigroup
Amazon.com, Inc. (NASDAQ:AMZN) had its Buy rating reiterated by Jefferies Financial Group
Applied Materials, Inc. (NASDAQ:AMAT) price target lowered to $63.00 by B. Riley
Airgain Inc (NASDAQ:AIRG) had its Outperform rating reiterated by William Blair
Kiwa Bio-Tech Products Group Corporation (OTCMKTS:KWBT) Files An 8-K Entry into a Material Definitive Agreement
ASCENT CAPITAL GROUP,INC. (NASDAQ:ASCMA) Files An 8-K Regulation FD Disclosure
SUPERVALU INC. (NYSE:SVU) Files An 8-K Submission of Matters to a Vote of Security Holders
Kiwa Bio-Tech Products Group Corporation (OTCMKTS:KWBT) Files An 8-K Entry into a Material Definitive Agreement
ASCENT CAPITAL GROUP,INC. (NASDAQ:ASCMA) Files An 8-K Regulation FD Disclosure
SUPERVALU INC. (NYSE:SVU) Files An 8-K Submission of Matters to a Vote of Security Holders
OraSure Technologies, Inc. (NASDAQ:OSUR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Global Medical REIT Inc. (NYSE:GMRE) Files An 8-K Entry into a Material Definitive Agreement
Market Morning: Gene Therapy Deregulation, Market Morning: Gene Therapy Deregulation Amp Exchange Traded Funds , SEC On...
EnergyFunders is democratizing Oil and Gas Investments. Exclusive Interview with CEO Casey...
Market Morning: Asia Down, India Pummeled, Sears on Death Bed, Turkey...
Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...
Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...
Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions.At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices.Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
0 Reviews:
Post Your Review